Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|13|7|901-910

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.13, Iss.7, 2012-09, pp. : 901-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Clinical Disposition and Metabolism of DM1, a Component of Trastuzumab Emtansine (T-DM1), in Sprague Dawley Rats

By  

Drug Metabolism Letters, Vol. 9, Iss. 2, 2015-08 ,pp. : 119-131

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer

By  

Current Drug Metabolism, Vol. 13, Iss. 7, 2012-09 ,pp. : 911-922

Bentham Science Publishers

Access to resources Recommend Favorite

Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice

By Jumbe Nelson   Xin Yan   Leipold Douglas   Crocker Lisa   Dugger Debra   Mai Elaine   Sliwkowski Mark   Fielder Paul   Tibbitts Jay  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 3, 2010-06 ,pp. : 221-242

Springer Publishing Company

Access to resources Recommend Favorite

Insulins for T1DM in pregnancy

By  

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Boswellia serrata: An Overall Assessment of In Vitro, Preclinical, Pharmacokinetic and Clinical Data

By Abdel-Tawab Mona  

Clinical Pharmacokinetics, Vol. 50, Iss. 6, 2011-06 ,pp. : 349-369

Adis International

Access to resources Recommend Favorite